Everest Group, Ltd. earnings call
Management prioritizes share repurchases due to undervalued stock
Everest Group reported a transformational Q4 2025, dominated by the divestiture of its commercial retail insurance business and a continued focus on simplifying operations. Management emphasized a disciplined underwriting environment, particularly in casualty and after softer Jan 1 property catastrophe renewals, and signaled a strong commitment to share buybacks. The company sold the renewal rights to its commercial retail insurance business to AIG for $426 million, leading to a recognized net benefit of $127.3 million.
Buzzberg read Management prioritizes share repurchases due to undervalued stock Everest Group reported a transformational Q4 2025, dominated by the divestiture of its commercial retail insurance business and a continued focus on simplifying operations. Management emphasized a disciplined underwriting environment, particularly in casualty and after softer Jan 1 property catastrophe renewals, and signaled a strong commitment to share buybacks. The company sold the renewal rights to its commercial retail insurance business to AIG for $426 million, leading to a recognized net benefit of $127.3 million. Read full analysisCollapse analysis
Everest Group reported a transformational Q4 2025, dominated by the divestiture of its commercial retail insurance business and a continued focus on simplifying operations. Management emphasized a disciplined underwriting environment, particularly in casualty and after softer Jan 1 property catastrophe renewals, and signaled a strong commitment to share buybacks. The company sold the renewal rights to its commercial retail insurance business to AIG for $426 million, leading to a recognized net benefit of $127.3 million.
- Group combined ratio was 98.4%, impacted by $216M of catastrophe losses and $122M of ADC premium.
- Management prioritizes share repurchases as stock trades at a discount to book value; repurchased $400M in Q4 and $100M in January 2026.
- Jan 1 renewals saw property cat rates down 10% globally, leading to a 2% reduction in total property limit deployed.
What matters now
The highest-signal changes from the call.
Expense ratio expected to be elevated but improve over 2026
Property cat rates down ~10% at Jan 1 renewals
Show 3 more callouts
Selective capacity deployment reduced property cat limit 2%
U.S. casualty pricing up to 20% above trend
Adverse development cover cost $122 million in Q4
Actuals
| Metric | Reported | Change |
|---|---|---|
| Revenue | $4.422B | Reported |
| EPS | $13.26 | Reported |
| Gross margin | 32.87% | Reported |
| Operating margin | 14.07% | Reported |
| Free cash flow | $-0.33B | Reported |
| Capex | $0B | Reported |
Forward guidance
| Metric | Period | Range | Midpoint | Status |
|---|---|---|---|---|
| Operating marginOTHER | FY2026 | 110% | 110% | Guided |
| Operating marginGW_S | FY2026 | 12%–13% | 12.5% | Guided |
| Operating margin | FY2026 | 6%–7% | 6.5% | Guided |
Management read
Measured
Management acknowledged market softening and strategic restructuring but expressed confidence in portfolio discipline and capital return priorities.
Companiesreturns since call
Partners
Everest has divested its retail commercial business to AIG, transitioning the portfolio and recognizing a gain, signaling a strategic retreat from that segment.
Evidence
“we sold the renewal rights to our European, U.S., and Asian commercial retail insurance businesses to AIG for a total consideration of $426 million”
Supply-chain alpha · 1returns since call
Everest reduced its global property catastrophe capacity deployment by 2% at Jan 1 renewals for the first time since 2022, despite rates having decreased by an average of 10%.
Evidence
“Total property limit deployed decreased for the first time since 2022 with a modest 2% reduction.”
Methodology & coverage
Management-only analysis. All 1 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.